Stephanie Diaz | Manager of Investor Relations |
Brian Lian | President and Chief Executive Officer |
Greg Zante | Chief Financial Officer |
Steven Seedhouse | Raymond James |
Joseph Pantginis | H.C. Wainwright |
Andy Hsieh | William Blair |
Jay Olson | Oppenheimer |
Yale Jen | Laidlaw & Company |
Welcome to the Viking Therapeutics 2022 Second Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode.
Following management’s prepared remarks we will hold a Q&A session. [Operator Instructions] As a reminder, this conference call is being recorded today, July 27, 2022. I would now like to turn the conference over to Viking’s Manager of Investor Relations, Stephanie Diaz.